The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Microbiome-derived bile acids and association with dietary fiber intake to anti-tumor responses in patients with melanoma receiving immune checkpoint blockade (ICB).
 
Nazli Dizman
Stock and Other Ownership Interests - Several pharmaceutical companies (I)
Consulting or Advisory Role - Eisai
 
Yufan Qiu
No Relationships to Disclose
 
Ehsan Irajizad
No Relationships to Disclose
 
Satabdi Saha
No Relationships to Disclose
 
Yan Jiang
No Relationships to Disclose
 
Julie Simon
No Relationships to Disclose
 
Elizabeth Burton
Consulting or Advisory Role - Philogen; Replimune
 
Erez Baruch
No Relationships to Disclose
 
Rodabe Amaria
Consulting or Advisory Role - Erasca, Inc; immatics; IO Biotech; KSQ Therapeutics; Merck; Obsidian Therapeutics; Replimune
Research Funding - Bristol-Myers Squibb (Inst); Erasc (Inst); Genentech (Inst); immatics (Inst); iovance Biotherapeutics (Inst); KSQ Therapeutics (Inst); Novartis (Inst); Obsidian Therapeutics (Inst); OnKure (Inst); Regeneron (Inst)
 
Isabella Glitza
Honoraria - Bristol Myers Squibb; Pfizer
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Leal Therapeutics; Midatech Pharma; Novartis; Sintetica
Speakers' Bureau - Array BioPharma
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst)
 
Hussein Tawbi
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Immunocore; IO Biotech; Iovance Biotherapeutics; Medicenna; Merck; Novartis; Pfizer; Regeneron
Research Funding - Bristol-Myers Squibb (Inst); Dragonfly Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); RAPT Therapeutics (Inst); Regeneron (Inst)
 
Philip Lorenzi
No Relationships to Disclose
 
Michael Davies
Consulting or Advisory Role - ABM; Apexigen; Array BioPharma; Bristol-Myers Squibb; Eisai; Genentech/Roche; Iovance Biotherapeutics; NanoString Technologies; Novartis; Nurix; Pfizer; Replimune
Research Funding - ABM (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lead Pharma (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Pfizer (Inst); Sanofi (Inst)
 
Jeffrey Gershenwald
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Novartis; Novartis; Philogen; Regeneron; Syndax
Patents, Royalties, Other Intellectual Property - mercator therapeutics; UpToDate
 
Christine Peterson
No Relationships to Disclose
 
Nadim Ajami
No Relationships to Disclose
 
Jennifer Wargo
Stock and Other Ownership Interests - Micronoma
Honoraria - Daiichi Sankyo/UCB Japan; EverImmune; Gustave Roussy Cancer Center; OSE Immunotherapeutics; Peerview
Consulting or Advisory Role - Daiichi Sankyo/UCB Japan; EverImmune; Gustave Roussy Cancer Center; OSE Immunotherapeutics; Peerview
Patents, Royalties, Other Intellectual Property - Patent submitted regarding the role of the microbiome in response to immune checkpoint blockade
Travel, Accommodations, Expenses - Gustave Roussy Cancer Center; Peerview
 
Johannes Fahrmann
No Relationships to Disclose
 
Carrie Daniel-MacDougall
No Relationships to Disclose
 
Jennifer McQuade
Honoraria - Reptimmune